Study #2019-0991
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
MD Anderson Study Status
Enrolling
Treatment Agent
tranexamic acid
Description
This is a drug study that will examine if inhaled tranexamic acid can improve mortality in patients with cancer-related pulmonary hemorrhage and respiratory failure as compared to usual care.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Pulmonary Hemorrhage, Cancer
Study phase:
Phase III
Physician name:
Nisha Rathi
Department:
Critical Care
For general questions about clinical trials:
1-888-912-0153
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.